Palle Christophersen

Ballerup, 2750, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Understanding paralogous epilepsy-associated GABAA receptor variants: Clinical implications, mechanisms, and potential pitfalls.

Understanding paralogous epilepsy-associated GABAA receptor variants: Clinical implications, mechanisms, and potential pitfalls.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: December 06, 2024

Distinct neurodevelopmental and epileptic phenotypes associated with gain- and loss-of-function GABRB2 variants.

Distinct neurodevelopmental and epileptic phenotypes associated with gain- and loss-of-function GABRB2 variants.

Journal: EBioMedicine

Published: January 05, 2024

The shortcoming of using glibenclamide in exploratory clinical headache provocation studies.

The shortcoming of using glibenclamide in exploratory clinical headache provocation studies.

Journal: Cephalalgia : an international journal of headache

Published: December 08, 2023

Pharmacological Profiling of KATP Channel Modulators: An Outlook for New Treatment Opportunities for Migraine.

Pharmacological Profiling of KATP Channel Modulators: An Outlook for New Treatment Opportunities for Migraine.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 22, 2022

Retroviral glycoprotein-mediated immune suppression via the potassium channel KCa3.1 - A new strategy for amelioration of inflammatory bowel diseases.

Retroviral glycoprotein-mediated immune suppression via the potassium channel KCa3.1 - A new strategy for amelioration of inflammatory bowel diseases.

Journal: Clinical immunology (Orlando, Fla.)

Published: April 21, 2022

Four phase 1 trials to evaluate the safety and pharmacokinetic profile of single and repeated dosing of SCO-101 in adult male and female volunteers.

Four phase 1 trials to evaluate the safety and pharmacokinetic profile of single and repeated dosing of SCO-101 in adult male and female volunteers.

Journal: Basic & clinical pharmacology & toxicology

Published: April 23, 2020

Characterization of AN6001, a positive allosteric modulator of α6β2-containing nicotinic acetylcholine receptors.

Characterization of AN6001, a positive allosteric modulator of α6β2-containing nicotinic acetylcholine receptors.

Journal: Biochemical pharmacology

Published: October 06, 2019

Characterization of AN317, a novel selective agonist of α6β2-containing nicotinic acetylcholine receptors.

Characterization of AN317, a novel selective agonist of α6β2-containing nicotinic acetylcholine receptors.

Journal: Biochemical pharmacology

Published: October 06, 2019

Pharmacology of Small- and Intermediate-Conductance Calcium-Activated Potassium Channels.

Pharmacology of Small- and Intermediate-Conductance Calcium-Activated Potassium Channels.

Journal: Annual review of pharmacology and toxicology

Published: July 25, 2019

Antibodies and venom peptides: new modalities for ion channels.

Antibodies and venom peptides: new modalities for ion channels.

Journal: Nature reviews. Drug discovery

Published: February 08, 2019

Identification of new molecular targets for PET imaging of the microglial anti-inflammatory activation state.

Identification of new molecular targets for PET imaging of the microglial anti-inflammatory activation state.

Journal: Theranostics

Published: February 17, 2018

Potassium channel expression and function in microglia: Plasticity and possible species variations.

Potassium channel expression and function in microglia: Plasticity and possible species variations.

Journal: Channels (Austin, Tex.)

Published: March 10, 2017

Showing 1-12 of 24

Last Updated: 09/26/2026